Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...

If you have type 1 or type 2 diabetes, your doctor might prescribe Toujeo. It’s a prescription diabetes medication used in adults and some children. To learn more about diabetes and how Toujeo is used ...

Toujeo (insulin glargine) is a prescription drug used to help manage blood sugar in people with type 1 or type 2 diabetes. Toujeo can cause side effects that range from mild to serious, such as weight ...

Toujeo is a long-acting form of insulin. It works by lowering the level of blood sugar in the body. It is not used for diabetic ketoacidosis. Toujeo is given as a subcutaneous injection. For ...

Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo ® (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve ...

Toujeo injection Sanofi announced new real-world data on Toujeo (insulin glargine injection) regarding change in HbA1c and occurrence of hypoglycemia in patients up to 6 months after switching to ...

PARIS, June 14, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that, in a pooled analysis, investigational therapy Toujeo ® (insulin glargine [rDNA origin] injection, 300 ...

PARIS, Feb. 25, 2015 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), a ...

Toujeo (insulin glargine) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat type 1 or type 2 diabetes. The drug is for use in adults as well as ...